• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Estimation of Serum YKL-40 by Real-Time Surface Plasmon Resonance Technology in North-Indian Asthma Patients.采用实时表面等离子体共振技术对北印度哮喘患者血清YKL-40进行检测
J Clin Lab Anal. 2017 Mar;31(2). doi: 10.1002/jcla.22028. Epub 2016 Sep 12.
2
The relationship between serum YKL-40 levels and severity of asthma.血清YKL-40水平与哮喘严重程度之间的关系。
Iran J Allergy Asthma Immunol. 2013 Jul 9;12(3):247-53.
3
Combined Assessment of Serum Periostin and YKL-40 May Identify Asthma-COPD Overlap.血清骨膜蛋白和 YKL-40 的联合评估可能有助于识别哮喘-COPD 重叠。
J Allergy Clin Immunol Pract. 2019 Jan;7(1):134-145.e1. doi: 10.1016/j.jaip.2018.06.015. Epub 2018 Jul 6.
4
YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E.哮喘患者的 YKL-40 及其与恶化、嗜酸性粒细胞和免疫球蛋白 E 的相关性。
Eur Respir J. 2010 Apr;35(4):757-60. doi: 10.1183/09031936.00034409.
5
Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.几丁质酶样蛋白 YKL-40 与炎症表型、抗哮喘反应性和未来加重相关。
Respir Res. 2019 May 22;20(1):95. doi: 10.1186/s12931-019-1051-9.
6
YKL-40 protein is a marker of asthma.YKL-40蛋白是哮喘的一个标志物。
J Asthma. 2011 Oct;48(8):767-72. doi: 10.3109/02770903.2011.611955. Epub 2011 Sep 8.
7
Role of YKL-40 in bronchial smooth muscle remodeling in asthma.YKL-40 在哮喘支气管平滑肌重塑中的作用。
Am J Respir Crit Care Med. 2012 Apr 1;185(7):715-22. doi: 10.1164/rccm.201105-0915OC. Epub 2012 Jan 26.
8
YKL-40 protein correlates with the phenotype of asthma.YKL-40蛋白与哮喘的表型相关。
Lung. 2015 Apr;193(2):189-94. doi: 10.1007/s00408-015-9693-y. Epub 2015 Feb 8.
9
Correlation between changes in serum YKL-40, LXRs, PPM1A, and TGF-β1 levels and airway remodeling and lung function in patients with bronchial asthma.支气管哮喘患者血清YKL-40、肝X受体(LXRs)、PPM1A和转化生长因子-β1(TGF-β1)水平变化与气道重塑及肺功能的相关性
J Asthma. 2024 Jul;61(7):698-706. doi: 10.1080/02770903.2023.2301426. Epub 2024 Feb 8.
10
A chitinase-like protein in the lung and circulation of patients with severe asthma.重度哮喘患者肺组织及循环系统中的一种几丁质酶样蛋白。
N Engl J Med. 2007 Nov 15;357(20):2016-27. doi: 10.1056/NEJMoa073600.

引用本文的文献

1
Recent Progress in Surface Plasmon Resonance Biosensors (2016 to Mid-2018).近年来表面等离子体共振生物传感器的研究进展(2016 年至 2018 年年中)。
Biosensors (Basel). 2018 Dec 16;8(4):132. doi: 10.3390/bios8040132.

本文引用的文献

1
YKL-40 in Asthma and its correlation with different clinical parameters.哮喘中的YKL-40及其与不同临床参数的相关性。
Iran J Allergy Asthma Immunol. 2014 Aug;13(4):271-7.
2
Serum based diagnosis of asthma using Raman spectroscopy: an early phase pilot study.基于拉曼光谱的血清学诊断哮喘:一项早期阶段的试点研究。
PLoS One. 2013 Nov 8;8(11):e78921. doi: 10.1371/journal.pone.0078921. eCollection 2013.
3
The relationship between serum YKL-40 levels and severity of asthma.血清YKL-40水平与哮喘严重程度之间的关系。
Iran J Allergy Asthma Immunol. 2013 Jul 9;12(3):247-53.
4
YKL-40 protein is a marker of asthma.YKL-40蛋白是哮喘的一个标志物。
J Asthma. 2011 Oct;48(8):767-72. doi: 10.3109/02770903.2011.611955. Epub 2011 Sep 8.
5
YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E.哮喘患者的 YKL-40 及其与恶化、嗜酸性粒细胞和免疫球蛋白 E 的相关性。
Eur Respir J. 2010 Apr;35(4):757-60. doi: 10.1183/09031936.00034409.
6
YKL-40--a novel biomarker in clinical practice?YKL-40——临床实践中的一种新型生物标志物?
Folia Med (Plovdiv). 2009 Jan-Mar;51(1):5-14.
7
Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.乳腺退化蛋白39(BRP-39)/几丁质酶3样蛋白1在Th2和IL-13诱导的组织反应及细胞凋亡中的作用
J Exp Med. 2009 May 11;206(5):1149-66. doi: 10.1084/jem.20081271. Epub 2009 May 4.
8
Chitinase activates protease-activated receptor-2 in human airway epithelial cells.几丁质酶可激活人气道上皮细胞中的蛋白酶激活受体-2。
Am J Respir Cell Mol Biol. 2008 Nov;39(5):530-5. doi: 10.1165/rcmb.2007-0410OC. Epub 2008 May 12.
9
Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.几丁质酶3样蛋白1(CHI3L1)的变异对血清YKL-40水平、哮喘风险和肺功能的影响。
N Engl J Med. 2008 Apr 17;358(16):1682-91. doi: 10.1056/NEJMoa0708801. Epub 2008 Apr 9.
10
Chitinase-like protein and asthma.几丁质酶样蛋白与哮喘。
N Engl J Med. 2008 Mar 6;358(10):1073-5; author reply 1075. doi: 10.1056/NEJMc073406.

采用实时表面等离子体共振技术对北印度哮喘患者血清YKL-40进行检测

Estimation of Serum YKL-40 by Real-Time Surface Plasmon Resonance Technology in North-Indian Asthma Patients.

作者信息

Naglot Sarla, Aggarwal Praveen, Dey Sharmistha, Dalal Krishna

机构信息

Department of Biophysics, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Department of Emergency Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

出版信息

J Clin Lab Anal. 2017 Mar;31(2). doi: 10.1002/jcla.22028. Epub 2016 Sep 12.

DOI:10.1002/jcla.22028
PMID:27616735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6816881/
Abstract

BACKGROUND

Many studies reported for estimating serum YKL-40 using ELISA or RIA methods. This study introduces the plausible utilization of real-time surface plasmon resonance (SPR) technology in investigating the expression of serum YKL-40 protein levels and ELISA method for serum IgE in bronchial asthma.

METHODS

A commercially available BIAcore 2000 instrument, based on SPR technology, was utilized for assessing serum YKL-40 levels in a control sample size of 45 and active sample size of 97. Antibody immobilization was optimized to obtain the best sensor performance and a sensitive analytic detection. A commercially available ELISA kit was utilized for detecting serum IgE to estimate allergic condition-associated asthma.

RESULTS

The results of SPR technology could distinctly classify with highly statistical significance, the asthma severities by estimating the elevated levels of YKL-40 in blood sera of minute quantities (up to 0.33 ng/ml), and thus differentiates superior utility in comparison with ELISA method. No statistically significant correlation of YKL-40 and IgE was observed.

CONCLUSIONS

Serum YKL-40 may be used as a protein marker in classifying asthma severity by applying SPR technology as a reliable, label-free, highly sensitive, and cost-effective tool.

摘要

背景

许多研究报道了使用酶联免疫吸附测定(ELISA)或放射免疫分析(RIA)方法来估计血清YKL-40。本研究介绍了实时表面等离子体共振(SPR)技术在研究血清YKL-40蛋白水平表达以及支气管哮喘患者血清IgE的ELISA方法中的合理应用。

方法

使用基于SPR技术的市售BIAcore 2000仪器,对45例对照样本和97例活性样本进行血清YKL-40水平评估。优化抗体固定以获得最佳传感器性能和灵敏的分析检测。使用市售ELISA试剂盒检测血清IgE以评估与过敏相关的哮喘。

结果

SPR技术的结果能够以高度统计学意义清晰地对哮喘严重程度进行分类,通过估计微量血清(高达0.33 ng/ml)中YKL-40水平的升高来实现,因此与ELISA方法相比具有更高的实用性。未观察到YKL-40与IgE之间具有统计学意义的相关性。

结论

通过将SPR技术作为一种可靠、无标记、高度灵敏且经济高效的工具,血清YKL-40可作为哮喘严重程度分类的蛋白质标志物。